CN100352841C - Antibiotic peptide and its coding sequence and uses - Google Patents
Antibiotic peptide and its coding sequence and uses Download PDFInfo
- Publication number
- CN100352841C CN100352841C CNB200510100850XA CN200510100850A CN100352841C CN 100352841 C CN100352841 C CN 100352841C CN B200510100850X A CNB200510100850X A CN B200510100850XA CN 200510100850 A CN200510100850 A CN 200510100850A CN 100352841 C CN100352841 C CN 100352841C
- Authority
- CN
- China
- Prior art keywords
- antibacterial peptide
- polynucleotide
- peptide
- antibiotic
- cdna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract description 12
- 230000003115 biocidal effect Effects 0.000 title abstract description 7
- 108091026890 Coding region Proteins 0.000 title 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims abstract description 54
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 17
- 239000002157 polynucleotide Substances 0.000 claims abstract description 17
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 10
- 239000002773 nucleotide Substances 0.000 claims abstract description 10
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 10
- 230000000295 complement effect Effects 0.000 claims abstract description 8
- 239000013604 expression vector Substances 0.000 claims description 8
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 abstract description 18
- 230000002147 killing effect Effects 0.000 abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 238000009360 aquaculture Methods 0.000 abstract description 6
- 201000009906 Meningitis Diseases 0.000 abstract description 2
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 241000607534 Aeromonas Species 0.000 abstract 1
- 241000230562 Flavobacteriia Species 0.000 abstract 1
- 241000588772 Morganella morganii Species 0.000 abstract 1
- 206010040047 Sepsis Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 229940076266 morganella morganii Drugs 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 description 25
- 108090000623 proteins and genes Proteins 0.000 description 16
- 241000357444 Epinephelus coioides Species 0.000 description 15
- 235000019688 fish Nutrition 0.000 description 15
- 241000251468 Actinopterygii Species 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- 238000002156 mixing Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 7
- 230000000845 anti-microbial effect Effects 0.000 description 7
- 238000013016 damping Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000321428 Epinephelus guttatus Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 244000144974 aquaculture Species 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 230000009465 prokaryotic expression Effects 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000009545 invasion Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- NMXKFWOEASXOGB-QSFUFRPTSA-N Ala-Ile-His Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NMXKFWOEASXOGB-QSFUFRPTSA-N 0.000 description 2
- 108050004290 Cecropin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KKUVRYLJEXJSGX-MXAVVETBSA-N Cys-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CS)N KKUVRYLJEXJSGX-MXAVVETBSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- CFZZDVMBRYFFNU-QWRGUYRKSA-N Leu-His-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O CFZZDVMBRYFFNU-QWRGUYRKSA-N 0.000 description 2
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- ZLGQEBCCANLYRA-RYUDHWBXSA-N Phe-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O ZLGQEBCCANLYRA-RYUDHWBXSA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- SYOMXKPPFZRELL-ONGXEEELSA-N Val-Gly-Lys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N SYOMXKPPFZRELL-ONGXEEELSA-N 0.000 description 2
- 241000544286 Vibrio anguillarum Species 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 230000009435 amidation Effects 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 241000607522 Aeromonas sobria Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- OMDNCNKNEGFOMM-BQBZGAKWSA-N Ala-Met-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O OMDNCNKNEGFOMM-BQBZGAKWSA-N 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 241000251557 Ascidiacea Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 244000097582 Cecropia peltata Species 0.000 description 1
- 241000252185 Cobitidae Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241001600125 Delftia acidovorans Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- PHONXOACARQMPM-BQBZGAKWSA-N Gly-Ala-Met Chemical compound [H]NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O PHONXOACARQMPM-BQBZGAKWSA-N 0.000 description 1
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- 241000269970 Limanda ferruginea Species 0.000 description 1
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 1
- ONGCSGVHCSAATF-CIUDSAMLSA-N Met-Ala-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O ONGCSGVHCSAATF-CIUDSAMLSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000276427 Poecilia reticulata Species 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- FRPNVPKQVFHSQY-BPUTZDHNSA-N Ser-Trp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N FRPNVPKQVFHSQY-BPUTZDHNSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000736110 Sphingomonas paucimobilis Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241001494106 Stenotomus chrysops Species 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- MICFJCRQBFSKPA-UMPQAUOISA-N Trp-Met-Thr Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)=CNC2=C1 MICFJCRQBFSKPA-UMPQAUOISA-N 0.000 description 1
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 1
- XNLUVJPMPAZHCY-JYJNAYRXSA-N Val-Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 XNLUVJPMPAZHCY-JYJNAYRXSA-N 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607594 Vibrio alginolyticus Species 0.000 description 1
- 241000607265 Vibrio vulnificus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000003021 clonogenic effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012997 ficoll-paque Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000012151 immunohistochemical method Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The present invention provides an antibiotic peptide, polynucleotide for coding the antibacterial peptide and the purpose of the antibacterial peptide. The antibiotic peptideamino contains acid sequences of 1 to 30 bits in SQ IDNO: 2. The polynucleotide for coding the antibiotic peptideamino is nucleotide sequence containing the amino acid sequences of 1 to 30 bits or-22 to 30 bits in a coding SQ IDNO: 2 or the complementary sequence of the amino acid sequences. The antibiotic peptide has obvious killing effect on various bacteria (comprising various bacteria aquatic products), and the lowest killing concentration for a minority of pseudomonades, Stutzeri pseudomonades, Morganella morganii, moderate aeromonas and sepsis flavobacteria of meningitis achieves less than 10mumol/L. The present invention can be used for preparing antimicrobial agent or bactericide, and is especially used for preventing and treating bacteriosis in aquiculture.
Description
Technical field
The present invention relates to a kind of antibacterial peptide, particularly Epinephelus coioides antimicrobial petide, the nucleotide sequence of this antibacterial peptide of encoding and the purposes of this antibacterial peptide.
Background technology
Antibacterial peptide (antimicrobial peptide) is the general name with germ resistance small peptide.Sweden scientist Steiner in 1981 etc. separate from cherish guppy giant silkworm (Hyatophora cecropia) pupa and obtain a kind of cecropin, and with its called after cecropin.Up till now, oneself finds that the small molecules small peptide of antibacterial peptide and similar antibacterial peptide extensively is present in organic sphere, comprises bacterium, animals and plants and the mankind.This endogenic antibacterial peptide synthesizes through inducing, and is playing an important role aspect the invasion of body opposing pathogenic agent.Antibacterial peptide has broad-spectrum bactericidal action, and great majority have than killing action gram-positive microorganism, and some then all works to gram-positive microorganism and negative bacterium, to some fungi, protozoon, especially drug tolerant bacteria is had killing action.
Along with the raising of people's living standard, more and more big to the demand of sea-food.Cabrilla is one of famous and precious seafood fish renowned in the world, and its delicious meat is nutritious, is subjected to liking of various places human consumer deeply.Because cultivation density constantly increases, and the pollution of the influence of mankind's activity, environment, cause cabrilla grow seedlings and the process of forming is subjected to virus, bacterium and parasitic attack, cause to culture surviving rate and be lower than 50%, become the principal element of restriction cabrilla aquaculture development.
For bacteriosis, main at present application microbiotic is prevented and treated.Consequence has caused environmental pollution; The quality taste of fish is descended; The resistance of pathogenic agent strengthens simultaneously, makes chemicals and antibiotic consumption increasing, but disease problem and end solve; Agricultural chemicals and residues of antibiotics have influenced the quality of fishery products, all once refuse the fishery products of import China because of the antibiotic remains problem as Japan and European Union member countries.Seeking the method for new biological control, transfer and develop the immune defense potentiality of cabrilla self, is the necessary means that guarantees food safety and environmental safety, is the grand strategy of carrying out healthy aquaculture, realizing the aquaculture Sustainable development.
Fish move in the water surrounding that is rich in various microorganism, and secular existence adapts to makes it form effective defense mechanism.The fish natural immunity is the first line of defence that opposing is infected, can effectively stop microorganism absorption, invade and duplicate.Because right and wrong are special, needn't depend on the identification to cause of disease special molecular structure, thereby can react to multiple invasion cause of disease; And this being swift in response, the not free delay is even if through inducing generation also to have only very short time dilation, stay less survival time to pathogenic agent like this.Think that at present it is even more important that nonspecific innate immunity is compared to warm blooded animal for fish, in opposing is infected, play a significant role.
Along with going deep into of research, some important fish antibacterial peptide genes are cloned just successively.Existing oneself is cloned into some antibacterial peptide genes from yellowtail flounder, perch, porgy.From some fish, obtained to have the active peptide of antibacterial peptide in addition, as leopard sole, extra large scholar's gill eel, Ascidian, loach, Nian etc.Studies show that fish antibacterial peptide is the important component part of fish body non-specific immunity system, when the fish body sustains damage or pathogenic micro-organism when invasion and attack, can produce antibacterial peptide rapidly with prevention with kill and wound the invasion of pathogenic micro-organism.Its resultant velocity is fast, and diffusion rapidly in vivo, flexible characteristic is that other high molecular weight protein (as antibody) and immunocyte are not available.
Studies confirm that at present many antibacterial peptides pathogenic micro-organism specific to fish even other animal all has killing activity.The minimum concentration of killing is many in micromole's level.Discovery cecropin-melittin recombinant peptides such as Jia and C hold amidated pleurocidin can protect silver salmon to resist the infection of Vibrio anguillarum (Vibrio anguillarum).Along with research to separation, structure and the function of aquaculture kind antibacterial peptide, transform and syntheticly not only had stability and high efficiency anti-microbial activity but also special antimicrobial spectrum of tool and harmless to a host simultaneously antibacterial peptide gene, and in prokaryotic cell prokaryocyte, eukaryotic cell or some algae, express by genetically engineered, to produce in batches, tackle the particularly newtype drug of resistant organism of aquaculture kind main pathogens with promising to be.
Summary of the invention
The purpose of this invention is to provide a kind of new antibacterial peptide, and the purposes of the nucleotide sequence of this antibacterial peptide of encoding and this antibacterial peptide.
The present invention passes through to make up Epinephelus coioide white corpuscle cDNA library, and by order-checking and screening, has obtained a kind of cDNA of Epinephelus coioides antimicrobial petide.Simultaneously, by artificial synthesis and prokaryotic expression carrier recombinant expression method, having obtained this antibacterial peptide cDNA encoded polypeptide fragment respectively, and had stronger anti-microbial effect through this polypeptide fragment of evidence, is a kind of new antibacterial peptide.
Antibacterial peptide of the present invention is characterized in that, it contains among the SEQ ID NO:2 1 to 30 aminoacid sequence.It can be the aminoacid sequence of 1 to 30 or-22 to 30 among the SEQ ID NO:2.1 to 30 aminoacid sequence among the preferred SEQ ID NO:2.
The present invention also provides the polynucleotide of the above antibacterial peptide of coding.These polynucleotide contain among the coding SEQ ID NO:2 1 to 30 or-22 to 30 s' nucleotide sequence of aminoacid sequence or their complementary sequence.Can be the nucleotide sequence of SEQ ID NO:1 or wherein 156 to 245 or 90 to 245 polynucleotide, or their complementary sequence.
SEQ ID NO:3 is the complementary sequence of SEQ ID NO:1 nucleotide sequence.
The present invention also provides a kind of expression vector, and it contains the described polynucleotide of claim 3,4 or 5.This expression vector can be to cut that above-mentioned polynucleotide are inserted in the site and the expression plasmid that is built at the multienzyme of prokaryotic expression carrier pRSETA (available from invitrogen company).
The present invention also provides a kind of recombinant bacterial strain, and it contains above-mentioned expression vector.It can be that above-mentioned expression vector transformed into escherichia coli (for example e. coli bl21) is obtained.
The present invention the experiment proved that, the antibacterial peptide of the invention described above has stronger killing action (referring to embodiment two, table 1) to various bacteria (comprising multiple aquatic products bacterium).Therefore, this antibacterial peptide can be used for preparing antiseptic-germicide, particularly as the antiseptic-germicide of the prevention and the treatment of hydrobiont bacteriosis.
Antibacterial peptide of the present invention can prepare by the following method:
1. according to the aminoacid sequence (for example sequence of 1~30 amino acids residue among the SEQ ID NO:2) of described antibacterial peptide, synthesize polypeptide, and C is held amidation with solid-phase synthesis.
2. the nucleotide sequence (for example 156~248 polynucleotide among the SEQ ID NO:1) of described antibacterial peptide of will encoding is cloned into recombinant expression vector, and the DNA after will recombinating is transformed into host cell, carries out recombinant expressed.Obtain this antibacterial peptide behind the purifying.
Antibacterial peptide of the present invention and polynucleotide sequence thereof also have following purposes:
1. the application in culture fishery: this antibacterial peptide can be by soaking, inject, make an addition to method such as feed, is used for prevention and treatment fish or other hydrobiological bacteriosis.
2. immune animal after this antibacterial peptide and the bovine serum albumin coupling can prepare and antibacterial peptide specificity bonded antibody.This antibody can be used for detecting the existence of solution antibacterial peptide, and detects the expression of antibacterial peptide different tissues in the fish body by the method for immunohistochemical methods.
With SEQ ID NO:1 or with its complementary polynucleotide (comprising DNA or RNA), or its fragment, after carrying out mark, can pass through technology such as Southern trace, Northern trace, gene chip, little display, detect the segmental existence of antibacterial peptide gene in the animal gene group, or detect the situation of transcribing of antibacterial peptide gene.
According to SEQ ID NO:1 or with its complementary polynucleotide design primer, in can detecting antibacterial peptide gene each be organized in animal body by reverse transcription-polymerase chain reaction (RT-PCR), the situation of transcribing of different developmental phases
Below in conjunction with specific embodiment the present invention is further described in detail.
Embodiment
Embodiment one: Epinephelus coioides antimicrobial petide cDNA obtains
The inventor uses the Clontech SMARTcDNA of company library construction test kit, made up Epinephelus coioide white corpuscle cDNA library, by picking cloning and sequencing at random, and will record sequence and compare, obtain the cDNA of antibacterial peptide with blast program and Genbank sequence.
1. the extraction of the total RNA of Epinephelus coioide white corpuscle
Healthy Epinephelus coioide (heavily about 600g), abdominal injection polyI:C (available from Amersham Pharmacia) 0.4ml, concentration is 2mg/ml.Behind the 72h,, add to the long-pending physiological saline that contains heparin of tetraploid from the tail vein haemospasia.This suspension slowly is added in the surface of the Ficoll-Paque Plus lymphocyte separation medium (available from Amersham Pharmacia) of two times of suspension volumes.After the balance in the centrifugal 30min of room temperature 400g.The white corpuscle in sucking-off middle layer washes twice with physiological saline, at every turn in the centrifugal 15min of 200g and abandon supernatant.Cell is resuspended with 1ml physiological saline, behind the cell counting count board counting, divides to be filled in the 1.5ml centrifuge tube, and 400g is centrifugal, and 2min abandons supernatant.(available from RocheDiagnostics company) extracts total RNA with Tripure reagent.
2.cDNA a chain is synthetic:
Total RNA (0.25 μ g/ μ l) 3 μ l
SMART III oligonucleotide 1 μ l
CDS III/3 ' PCR primer 1 μ l
Cumulative volume 5 μ l
With above composition mixing, on whizzer, get rid of, hatch 2min in 72 ℃, then put ice bath 2min, on whizzer, get rid of again, in pipe, add successively then:
5 * 1
StChain damping fluid 2.0 μ l
DTT(20mmol/L) 1.0μl
dNTP mix(10mmol/L) 1.0μl
SUPERSCRIPT
TMII ThermoScript II (200u/ μ l) 1.0 μ l
Cumulative volume 10.0 μ l
Blow and beat the above composition of mixing gently, on whizzer, get rid of.Add 1 mineral oil, in 42 ℃ of incubation 1h.Taking out pipe puts ice bath to stop the first chain cDNA synthetic.
3.cDNA long range PCR:
Getting 0.5ml Eppendorf pipe adds successively:
1
StChain cDNA 2 μ l
Deionized water 80 μ l.
10 * cDNA PCR damping fluid, 10 μ l
50×dNTP mix 2μl
5 ' PCR primer 2 μ l
CDS III/3 ' PCR primer 2 μ l
50 * Advantage cDNA polysaccharase mixture, 2 μ l
Cumulative volume 100 μ l
Flick the above composition of tube wall mixing, on centrifugal, get rid of.Add 2 mineral oil, reaction tubes is placed on the PCR instrument that is preheated to 95 ℃, carry out long range PCR (LD-PCR).
Response procedures is: (1) 95 ℃ of 1min; (2) 95 ℃ of 15sec, 68 ℃ of 6min, 30 circulations.
Reaction finishes, and gets 5 μ l PCR products, on 1.1% sepharose, is that molecular weight standard carries out electrophoresis detection with 0.1 μ g 1kb DNA Ladder.
4.LD-PCR the protease K digesting of product:
Add 50 μ l LD-PCR products and 2 μ l Proteinase Ks (20 μ g/ μ l) in a sterilization 0.5ml pipe, mixing, centrifugal slightly.Place 45 ℃ to hatch 20min reaction tubes, centrifugal slightly.Add 50 μ l deionized waters to pipe, add 100 μ l phenol again: chloroform: primary isoamyl alcohol (25: 24: 1), slowly put upside down 1-2min back and forth.With the centrifugal 5min of 14,000 * g.Move upper strata water to sterilization 0.5ml pipe, add 10 μ l 3mol/L NaAc solution, 1.3 μ l glycogen solution (20 μ g/ μ l), 260 μ l, 95% ethanol (room temperature), immediately in room temperature with the centrifugal 20min of 14,000 * g.Carefully remove supernatant, precipitate with 100 μ l, 80% washing with alcohol.Dry air precipitation 8~10min.Then add the resuspended precipitation of 79 μ l deionized waters.
5.cDNA carrying out Sfi I enzyme cuts:
Getting a sterilization 0.5ml pipe adds successively:
cDNA 79μl
10 * Sfi I damping fluid, 10 μ l
Sfi I enzyme (20u/ μ l) 10 μ l
100×BSA 1μl
Cumulative volume 100 μ l
With above composition thorough mixing in the pipe, on centrifugal, get rid of.Place 50 ℃ of incubation 2h.Then add 2 μ l, 1% dimethylbenzene green grass or young crops, thorough mixing.
6.cDNA portions from:
Get 16 1.5ml pipes, also be placed on the test-tube stand successively by the 1-16 serial number.The blue or green mixture of cDNA that 100 μ l Sfi I enzymes are cut and dimethylbenzene dropwise joins the center on CHROMA SPIN-400 pillar mesostroma surface carefully, allows sample fully be absorbed by matrix.Wash post with 100 μ l CHROMA post damping fluids.After treating that damping fluid flows to end, add 600 μ l CHROMA post damping fluids to post, begin dropwise to collect effusive drop to 1 immediately
#-16
#Pipe (about 35 μ l/ pipe).Every pipe is got 3 μ l respectively and is collected liquid in 1.1% sepharose 150V electrophoresis 10min, is molecular weight standard with 0.1 μ g 1kb DNA.Under ultraviolet lamp, observe the brightness of cDNA band.Brightness is the highest, and promptly 3 pipes that cDNA content is the highest are collected liquid and are concentrated to 1.5ml pipe, add 1/10 volume 3mol/L NaAc (pH4.8), 1.3 μ l glycogens (20mg/ml), 2.5 times of volume 95% ethanol (20 ℃), put upside down back and forth lentamente.Pipe is placed-20 ℃ put 1h.The centrifugal 20min of 14,000 * g carefully removes supernatant under the room temperature, and dry air 8~10min is with the resuspended precipitation of 7 μ l deionized waters.
7.cDNA with being connected of carrier
Because it is best to be difficult to determine that many a spot of cDNA and carrier are connected effect, so carried out a series of pre-connections and packing reaction.In 3 0.5ml pipes, set up 3 groups of connection-packing reactions as follows:
1 # | 2 # | 3 # | |
CDNA carrier (500ng/ μ l) 10 * connection buffer A TP (10mmol/L) T4 dna ligase (400u/ μ l) deionized water cumulative volume (μ l) | 0.5 1.0 0.5 0.5 0.5 2.0 5.0 | 1.0 1.0 0.5 0.5 0.5 1.5 5.0 | 1.5 1.0 0.5 0.5 0.5 1.0 5.0 |
Get rid of on centrifugal after respectively managing mixing above, 16 ℃ are incubated overnight on the PCR instrument.
8. the packing that connects product: undertaken by MaxPlax Lambda packaging extract specification sheets.
9. insert the pcr amplification of son:
From the library flat board single plaque of picking at random, add to 500 μ l lambda particles phage diluents, room temperature is placed 1-2h, so that phage discharges from agar.Get 1 μ l phage and do template, carry out PCR, identify the size of inserting son with Advantage cDNAPCR test kit (Clontech).
The primer:
λ TriplEx 5 ' long distance is inserted son screening primer (AP1): 5 '-CTC GGG AAG CGC GCC ATT GTG TTG GT-3 ',
λ TriplEx 3 ' long distance is inserted son screening primer (AP2): 5 '-ATA CGA CTC ACT ATA GGG CGA ATT GGC C-3 '
PCR reaction mixture: 10 * PCR damping fluid, 5 μ l, AP1 and AP2 primer (every kind 10 μ mol/L) 2 μ l, 4 * dNTP mixed solution (every kind of 10mmol/L), 1 μ l, cDNA polysaccharase mixture 1 μ l, water 40.5 μ l.
The PCR loop parameter: 94 ℃, 10min; 30 circulations: 94 ℃, 30s; 68 ℃, 3min.68℃,3min。Get 5 μ l after PCR finishes and carry out agarose gel electrophoresis.Greater than the PCR product of 500bp, reclaim test kit (giving birth to worker's biotechnology company limited) with PCR product glue and reclaim purifying available from Shanghai.
10. sequencing: sea base health biotechnology company limited finishes in the trust.
11. the analysis of sequencing result:
With the BLAST N and the BLAST X instrument of the U.S. state-run biotechnology information center (NCBI), carry out homology relatively with the database of GenBank.The cDNA that finds a sequence and other antibacterial peptide has certain homology, and confirming as by analysis is the antibacterial peptide cDNA sequence of Epinephelus coioide, and this sequence is shown in SEQIDNO:1.
Embodiment two: the synthetic mensuration that reaches minimum bactericidal concentration of the solid state chemistry of antibacterial peptide
1. the solid state chemistry of antibacterial peptide is synthetic:
Press the sequence of 1 to the 30 amino acids residue of SEQ ID NO:2, entrust the synthetic polypeptide of Shenzhen writing brush space Bioisystech Co., Ltd, and with the C-terminal amidation.Synthetic back is purified, reaches 85% purity.
2. the mensuration of minimum bactericidal concentration
Different bacterium is spent the night based on 37 ℃ of shaking culture with the nutrient broth liquid culture.The bacterium that will spend the night is diluted to about 2 * 10 with the nutrient broth liquid nutrient medium
5Every milliliter of (CFU ml of clonogenic unit
-1).Get the above-mentioned synthetic antibacterial peptide solution (400 μ g/ml to 0.5 μ g/ml) that obtains with 1nnol/L acetate buffer solution (pH4.0) dilution of 25 μ l bacterium liquid and equal-volume different concns respectively and cultivate mixing in the plate hole at 96 porocytes, bacterium liquid and equal-volume acetate buffer solution mixing are as contrast, be put in 37 ℃ of incubation 1h in the bacteriological incubator, the liquid of getting then in the hole is applied to nutrient broth solid medium flat board, puts 37 ℃ and is incubated overnight.Number goes out the bacterium colony number on the flat board.Compare with the flat board of contrast, colony number less than the antibacterial peptide concentration of the flat board of dull and stereotyped 1% number of contrast as to the minimum bactericidal concentration of this bacterium (minimal bacteriacide concentration, MBC).The result is as shown in table 1.
Table 1 Epinephelus coioides antimicrobial petide is to the minimum bactericidal concentration of some bacteriums
Bacteria name | The minimum concentration (μ M) of killing |
Pseudomonas paucimobilis Pseudomonas stutzeri Mo Genermo root fungus Aeromonas sobria meningitis septic Flavobacterium mermaid vibrios vibrio parahaemolytious enterobacter cloacae vibrio alginolyticus Vibrio vulnificus Aeromonas hydrophila streptococcus fecalis pseudomonas acidovorans domestic animal staphylococcus bacillus coli DH 5 alpha | 7.92 7.92 7.92 7.92 7.92 15.83 31.67 31.67 31.67 >63.34 >63.34 >63.34 >63.34 >63.34 >63.34 |
As shown in table 1, this antibacterial peptide is to various bacteria, and particularly the most important pathogenic bacteria unit cell of fish mushroom has good killing action, great prospect aspect prevention for preparing antiseptic-germicide and fish bacteriosis and treatment.
Embodiment three: the cabrilla antibacterial peptide is recombinant expressed prokaryotic expression carrier
Cut the site according to two terminal sequences of 156~248 polynucleotide among the SEQ ID NO:1 and the multienzyme of prokaryotic expression carrier pRSET A, synthetic a pair of primer, sequence is as follows: upstream primer, 5 '-GC
GGATCCATC TTT GGA TTG CTT CTC-3 ', wherein underscore partly is the BamHI restriction enzyme site; Downstream primer, 5 '-CG
GAATTCCTA GGT CAT CCA GCT GCT-3 ', wherein underscore partly is the EcoRI restriction enzyme site.
Pcr amplification, gene clone are carried out all according to a conventional method.The about 130bp of PCR product.Goal gene (nucleotide sequence of SEQ ID NO:1 or 156~248 polynucleotide wherein) is cloned on the prokaryotic expression carrier pRSET A, be built into expression plasmid pRSET-Epi, cut through enzyme and identify with sequencing analysis and show that cloned genes is a goal gene.
With expression plasmid pRSET-Epi transformed into escherichia coli BL21.The engineering bacteria that contains goal gene grows into OD at 37 ℃
600=0.5 o'clock, add the isopropylthio-that final concentration is 0.1M (IPTG) immediately and induced 4 hours.Collect thalline, obtain the target protein that molecular weight is 16kD through separation and purification.Show through immunoblotting: the aminoacid sequence of resulting target protein conforms to the N-terminal of SEQ ID NO:2.
Sequence table
<110〉Zhongshan University
<120〉a kind of antibacterial peptide and encoding sequence thereof and purposes
<160>3
<210>1
<211>737
<212>cDNA
<213〉Epinephelus coioide (Epinephelus coioides)
<220>
<221>CDS
<222>(90)…(248)
<400>1
aagacacaga tatattacat accctgtgaa ctctcactac tctgtttgag agcagcctt 60
ttgcctttga ctctgagtca gtggaaagg atg aag tgt act gtg gtc ttt ctt 113
Met Lys Cys Thr Val Val Phe Leu
-20 -15
gtg ttg tcc atg gtc gta ttc atg gct gaa cct gga gag tgt atc ttt 161
Val Leu Ser Met Val Val Phe Met Ala Glu Phe Gly Glu Cys Ile Phe
-10 -5 -1 1
gga ttg ctt ctc cac gga gcc att cac gtt ggc aaa ctg atc cat ggg 209
Gly Leu Leu Leu His gly Ala Ile His Val Gly Lys leu Ile His Gly
5 10 15
ctg tta ggc gcc atg ggg aag agc agc tgg atg acc tag agcagctgga 258
Leu Leu Gly Ala Met Gly Lys Ser Ser Trp Met Thr ***
20 25 30
caaacgtgca cttgattata acccggggcg gcctggtttt gactagactg cgggggcaac 318
tctgaagcta catgttggat ccccgtcgaa aacgagatgc tctatctcaa gaggctatcc 378
taaataaatt gaattgaatt gaattgaatt ggattaaaag atttgcttct ggcttcttcc 438
tcttcaaaat gagaaagaaa agtgtctatc aagcgcagaa accatcgctt gaaaaacaca 498
ctgagtgatg ataacatttt gaattaattt ggtacagtga aagtcgtaaa actaaaataa 558
aataaaattg cctttaaata catgaaaaaa gtaaaaaaga attatgacgc atgtttttat 618
gttccgtgtt gttgacatgg tttttgatac tctattacat tcatgtgcaa agcaaaatct 678
tctatggaca ataaaggttt cattgattcg caaaaaaaaaa aaaaaaaaaa aaaaaaaa 737
<210>2
<211>52
<212>PRT
<213〉Epinephelus coioide (Epinephelus coioides)
<400>2
Met Lys Cys Thr Val Val Phe Leu Val Leu Ser Met Val Val Phe Met Ala Glu
-20 -15 -10 -5
Phe Gly Glu Cys Ile Phe Gly Leu Leu Leu His gly Ala Ile His Val Gly Lys
-1 1 5 10
leu Ile His Gly Leu Leu Gly Ala Met Gly Lys Ser Ser Trp Met Thr ***
15 20 25 30
<210>3
<211>737
<212>cDNA
<213〉Epinephelus coioide (Epinephelus coioides)
<400>3
aagacacaga tatattacat accctgtgaat ctctcactac tctgtttgag agcagcctt 60
ttgcctttga ctctgagtca gtggaaagga tgaagtgtac tgtggtcttt cttgtgttgt 120
ccatggtcgt attcatggct gaacctggag agtgtatctt tggattgctt ctccacggag 180
ccattcacgt tggcaaactg atccatgggc tgttaggcgc catggggaag agcagctgga 240
tgacctagag cagctggaca aacgtgcact tgattataac ccggggcggc ctggttttga 300
ctagactgcg ggggcaactc tgaagctaca tgttggatcc ccgtcgaaaa cgagatgctc 360
tatctcaaga ggctatccta aataaattga attgaattga attgaattgg attaaaagat 420
ttgcttctgg cttcttcctc ttcaaaatga gaaagaaaag tgtctatcaa gcgcagaaac 480
catcgcttga aaaacacact gagtgatgat aacattttga attaatttgg tacagtgaaa 540
gtcgtaaaac taaaataaaa taaaattgcc tttaaataca tgaaaaaagt aaaaaagaat 600
tatgacgcat gtttttatgt tccgtgttgt tgacatggtt tttgatactc tattacattc 660
atgtgcaaag caaaatcttc tatggacaat aaaggtttca ttgattcgca aaaaaaaaaa 720
aaaaaaaaaa aaaaaaa 737
Claims (8)
1. an antibacterial peptide is made up of the aminoacid sequence shown in 1 to 30 among the SEQ ID NO:2.
2. polynucleotide of the described antibacterial peptide of claim 1 of encoding.
3. according to the described polynucleotide of claim 2, it is characterized in that it is 1 to 30 the nucleotide sequence of aminoacid sequence or their complementary sequence among the coding SEQ ID NO:2.
4. according to the described polynucleotide of claim 3, it is characterized in that it is 156 to 245 nucleotide sequence or its complementary sequence among the SEQ ID NO:1.
5. an expression vector is characterized in that, it contains the described polynucleotide of claim 2,3 or 4.
6. a recombinant bacterial strain is characterized in that, it contains the described expression vector of claim 5.
7. according to the described recombinant bacterial strain of claim 6, it is characterized in that it obtains the described expression vector transformed into escherichia coli of claim 5.
8. the application of the described antibacterial peptide of claim 1 in the preparation antiseptic-germicide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510100850XA CN100352841C (en) | 2005-11-03 | 2005-11-03 | Antibiotic peptide and its coding sequence and uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510100850XA CN100352841C (en) | 2005-11-03 | 2005-11-03 | Antibiotic peptide and its coding sequence and uses |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1763092A CN1763092A (en) | 2006-04-26 |
CN100352841C true CN100352841C (en) | 2007-12-05 |
Family
ID=36747431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510100850XA Expired - Fee Related CN100352841C (en) | 2005-11-03 | 2005-11-03 | Antibiotic peptide and its coding sequence and uses |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100352841C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102140130B (en) * | 2010-11-12 | 2013-03-27 | 中国科学院海洋研究所 | Antibacterial peptide and use thereof |
CN107410362A (en) * | 2017-07-03 | 2017-12-01 | 安徽省黄淮兽药有限公司 | A kind of high-efficiency environment friendly aquatic products cultivates bactericide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1542017A (en) * | 2003-11-07 | 2004-11-03 | 中山大学 | An antibiotic peptide and its coded sequence and use |
CN1678632A (en) * | 2002-08-22 | 2005-10-05 | 加拿大国家研究所 | A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
-
2005
- 2005-11-03 CN CNB200510100850XA patent/CN100352841C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1678632A (en) * | 2002-08-22 | 2005-10-05 | 加拿大国家研究所 | A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
CN1542017A (en) * | 2003-11-07 | 2004-11-03 | 中山大学 | An antibiotic peptide and its coded sequence and use |
Also Published As
Publication number | Publication date |
---|---|
CN1763092A (en) | 2006-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Arockiaraj et al. | Crustin, a WAP domain containing antimicrobial peptide from freshwater prawn Macrobrachium rosenbergii: immune characterization | |
Liu et al. | Molecular cloning and expression profile of putative antilipopolysaccharide factor in Chinese shrimp (Fenneropenaeus chinensis) | |
CN101191129A (en) | Gene engineering domestic silkworm antibiotic peptide and its preparation method and application | |
He et al. | A goose-type lysozyme gene in Japanese scallop (Mizuhopecten yessoensis): cDNA cloning, mRNA expression and promoter sequence analysis | |
Li et al. | Molecular cloning and expression analysis of C-type lectin (RpCTL) in Manila clam Ruditapes philippinarum after lipopolysaccharide challenge | |
CN109576275A (en) | A kind of Cynoglossus semilaevis antibacterium disease related gene and its application method | |
Vaseeharan et al. | Molecular cloning, sequence analysis and expression of Fein-Penaeidin from the haemocytes of Indian white shrimp Fenneropenaeus indicus | |
Wang et al. | Molecular characterization and expression patterns of the big defensin gene in freshwater mussel (Hyriopsis cumingii) | |
CN101182360A (en) | Fusion protein having antibiotic function and uses thereof | |
CN102304484A (en) | New strain of pseudoalteromonas flavipulchra and use thereof | |
CN100352841C (en) | Antibiotic peptide and its coding sequence and uses | |
CN101525617B (en) | Eriocheir sinensis Crustin-1 gene and in-vitro recombination expression | |
CN101550183A (en) | Antibacterial peptide and construction and application thereof | |
De Zoysa et al. | Microarray analysis of gene expression in disk abalone Haliotis discus discus after bacterial challenge | |
CN1238378C (en) | An antibiotic peptide and its coded sequence and use | |
CN107602686B (en) | Polypeptide with resistance to gram-positive bacteria | |
CN100402552C (en) | Antibiotic peptide and its code sequence and use | |
CN101921788B (en) | Meretrix lysozyme gene and coding protein and application thereof | |
CN102051363A (en) | Clam ferroprotein gene as well as coding protein and application of in vitro recombinant expression product of same | |
Zhang et al. | Two LRR-only proteins involved in antibacterial defense and prophenoloxidase system of swimming crab Portunus trituberculatus | |
CN101565703B (en) | Eriocheir sinensis Crustin-2 gene and application of recombinant protein thereof | |
CN103484466A (en) | Diamondback moth antibacterial peptide moricin, preparation method and application thereof | |
CN102337271A (en) | Portunus trituberculatus anti-lipopolysaccharide factor PtALF-2 gene and encoding proteins and application thereof | |
CN108251440B (en) | Sinonovacula constricta lysozyme gene, coding protein and construction method and application of recombinant sinonovacula constricta lysozyme gene engineering bacteria | |
CN101164431A (en) | Feed additive with antibiotic function and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071205 Termination date: 20101103 |